[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

COVID-19 Impact on Global Acute Kidney Injury Treatment Market Size, Status and Forecast 2020-2026

September 2020 | 93 pages | ID: CDF3C4F278C8EN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report focuses on the global Acute Kidney Injury Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Acute Kidney Injury Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
  • Quark Pharmaceuticals, Inc.
  • Baxter International, Inc.
  • Fresenius Medical Care AG & Co. KGaA
  • LG Chem
  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Melsungen AG
  • Angion Biomedica Corp
Market segment by Type, the product can be split into
  • Prerenal Acute Kidney Injury
  • Postrenal Acute Kidney Injury
  • Intrinsic Renal Acute Kidney Injury
Market segment by Application, split into
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
Market segment by Regions/Countries, this report covers
  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central & South America
The study objectives of this report are:
  • To analyze global Acute Kidney Injury Treatment status, future forecast, growth opportunity, key market and key players.
  • To present the Acute Kidney Injury Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
  • To strategically profile the key players and comprehensively analyze their development plan and strategies.
  • To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Acute Kidney Injury Treatment are as follows:
  • History Year: 2015-2019
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Acute Kidney Injury Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Acute Kidney Injury Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Prerenal Acute Kidney Injury
  1.4.3 Postrenal Acute Kidney Injury
  1.4.4 Intrinsic Renal Acute Kidney Injury
1.5 Market by Application
  1.5.1 Global Acute Kidney Injury Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Ambulatory Surgical Centers
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Acute Kidney Injury Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Acute Kidney Injury Treatment Industry
    1.6.1.1 Acute Kidney Injury Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Acute Kidney Injury Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Acute Kidney Injury Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Acute Kidney Injury Treatment Market Perspective (2015-2026)
2.2 Acute Kidney Injury Treatment Growth Trends by Regions
  2.2.1 Acute Kidney Injury Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Acute Kidney Injury Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Acute Kidney Injury Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Acute Kidney Injury Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Acute Kidney Injury Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Acute Kidney Injury Treatment Players by Market Size
  3.1.1 Global Top Acute Kidney Injury Treatment Players by Revenue (2015-2020)
  3.1.2 Global Acute Kidney Injury Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Acute Kidney Injury Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Acute Kidney Injury Treatment Market Concentration Ratio
  3.2.1 Global Acute Kidney Injury Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Acute Kidney Injury Treatment Revenue in 2019
3.3 Acute Kidney Injury Treatment Key Players Head office and Area Served
3.4 Key Players Acute Kidney Injury Treatment Product Solution and Service
3.5 Date of Enter into Acute Kidney Injury Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Acute Kidney Injury Treatment Historic Market Size by Type (2015-2020)
4.2 Global Acute Kidney Injury Treatment Forecasted Market Size by Type (2021-2026)

5 ACUTE KIDNEY INJURY TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Acute Kidney Injury Treatment Market Size by Application (2015-2020)
5.2 Global Acute Kidney Injury Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Acute Kidney Injury Treatment Market Size (2015-2020)
6.2 Acute Kidney Injury Treatment Key Players in North America (2019-2020)
6.3 North America Acute Kidney Injury Treatment Market Size by Type (2015-2020)
6.4 North America Acute Kidney Injury Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Acute Kidney Injury Treatment Market Size (2015-2020)
7.2 Acute Kidney Injury Treatment Key Players in Europe (2019-2020)
7.3 Europe Acute Kidney Injury Treatment Market Size by Type (2015-2020)
7.4 Europe Acute Kidney Injury Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Acute Kidney Injury Treatment Market Size (2015-2020)
8.2 Acute Kidney Injury Treatment Key Players in China (2019-2020)
8.3 China Acute Kidney Injury Treatment Market Size by Type (2015-2020)
8.4 China Acute Kidney Injury Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Acute Kidney Injury Treatment Market Size (2015-2020)
9.2 Acute Kidney Injury Treatment Key Players in Japan (2019-2020)
9.3 Japan Acute Kidney Injury Treatment Market Size by Type (2015-2020)
9.4 Japan Acute Kidney Injury Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Acute Kidney Injury Treatment Market Size (2015-2020)
10.2 Acute Kidney Injury Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Acute Kidney Injury Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Acute Kidney Injury Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Acute Kidney Injury Treatment Market Size (2015-2020)
11.2 Acute Kidney Injury Treatment Key Players in India (2019-2020)
11.3 India Acute Kidney Injury Treatment Market Size by Type (2015-2020)
11.4 India Acute Kidney Injury Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Acute Kidney Injury Treatment Market Size (2015-2020)
12.2 Acute Kidney Injury Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Acute Kidney Injury Treatment Market Size by Type (2015-2020)
12.4 Central & South America Acute Kidney Injury Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Quark Pharmaceuticals, Inc.
  13.1.1 Quark Pharmaceuticals, Inc. Company Details
  13.1.2 Quark Pharmaceuticals, Inc. Business Overview and Its Total Revenue
  13.1.3 Quark Pharmaceuticals, Inc. Acute Kidney Injury Treatment Introduction
  13.1.4 Quark Pharmaceuticals, Inc. Revenue in Acute Kidney Injury Treatment Business (2015-2020))
  13.1.5 Quark Pharmaceuticals, Inc. Recent Development
13.2 Baxter International, Inc.
  13.2.1 Baxter International, Inc. Company Details
  13.2.2 Baxter International, Inc. Business Overview and Its Total Revenue
  13.2.3 Baxter International, Inc. Acute Kidney Injury Treatment Introduction
  13.2.4 Baxter International, Inc. Revenue in Acute Kidney Injury Treatment Business (2015-2020)
  13.2.5 Baxter International, Inc. Recent Development
13.3 Fresenius Medical Care AG & Co. KGaA
  13.3.1 Fresenius Medical Care AG & Co. KGaA Company Details
  13.3.2 Fresenius Medical Care AG & Co. KGaA Business Overview and Its Total Revenue
  13.3.3 Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Treatment Introduction
  13.3.4 Fresenius Medical Care AG & Co. KGaA Revenue in Acute Kidney Injury Treatment Business (2015-2020)
  13.3.5 Fresenius Medical Care AG & Co. KGaA Recent Development
13.4 LG Chem
  13.4.1 LG Chem Company Details
  13.4.2 LG Chem Business Overview and Its Total Revenue
  13.4.3 LG Chem Acute Kidney Injury Treatment Introduction
  13.4.4 LG Chem Revenue in Acute Kidney Injury Treatment Business (2015-2020)
  13.4.5 LG Chem Recent Development
13.5 Asahi Kasei Medical Co., Ltd.
  13.5.1 Asahi Kasei Medical Co., Ltd. Company Details
  13.5.2 Asahi Kasei Medical Co., Ltd. Business Overview and Its Total Revenue
  13.5.3 Asahi Kasei Medical Co., Ltd. Acute Kidney Injury Treatment Introduction
  13.5.4 Asahi Kasei Medical Co., Ltd. Revenue in Acute Kidney Injury Treatment Business (2015-2020)
  13.5.5 Asahi Kasei Medical Co., Ltd. Recent Development
13.6 B. Braun Melsungen AG
  13.6.1 B. Braun Melsungen AG Company Details
  13.6.2 B. Braun Melsungen AG Business Overview and Its Total Revenue
  13.6.3 B. Braun Melsungen AG Acute Kidney Injury Treatment Introduction
  13.6.4 B. Braun Melsungen AG Revenue in Acute Kidney Injury Treatment Business (2015-2020)
  13.6.5 B. Braun Melsungen AG Recent Development
13.7 Angion Biomedica Corp
  13.7.1 Angion Biomedica Corp Company Details
  13.7.2 Angion Biomedica Corp Business Overview and Its Total Revenue
  13.7.3 Angion Biomedica Corp Acute Kidney Injury Treatment Introduction
  13.7.4 Angion Biomedica Corp Revenue in Acute Kidney Injury Treatment Business (2015-2020)
  13.7.5 Angion Biomedica Corp Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES

Table 1. Acute Kidney Injury Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Acute Kidney Injury Treatment Revenue
Table 3. Ranking of Global Top Acute Kidney Injury Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Acute Kidney Injury Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Prerenal Acute Kidney Injury
Table 6. Key Players of Postrenal Acute Kidney Injury
Table 7. Key Players of Intrinsic Renal Acute Kidney Injury
Table 8. COVID-19 Impact Global Market: (Four Acute Kidney Injury Treatment Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Acute Kidney Injury Treatment Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Acute Kidney Injury Treatment Players to Combat Covid-19 Impact
Table 13. Global Acute Kidney Injury Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Acute Kidney Injury Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Acute Kidney Injury Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Acute Kidney Injury Treatment Market Share by Regions (2015-2020)
Table 17. Global Acute Kidney Injury Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Acute Kidney Injury Treatment Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Acute Kidney Injury Treatment Market Growth Strategy
Table 23. Main Points Interviewed from Key Acute Kidney Injury Treatment Players
Table 24. Global Acute Kidney Injury Treatment Revenue by Players (2015-2020) (Million US$)
Table 25. Global Acute Kidney Injury Treatment Market Share by Players (2015-2020)
Table 26. Global Top Acute Kidney Injury Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Kidney Injury Treatment as of 2019)
Table 27. Global Acute Kidney Injury Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Acute Kidney Injury Treatment Product Solution and Service
Table 30. Date of Enter into Acute Kidney Injury Treatment Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Acute Kidney Injury Treatment Market Size by Type (2015-2020) (Million US$)
Table 33. Global Acute Kidney Injury Treatment Market Size Share by Type (2015-2020)
Table 34. Global Acute Kidney Injury Treatment Revenue Market Share by Type (2021-2026)
Table 35. Global Acute Kidney Injury Treatment Market Size Share by Application (2015-2020)
Table 36. Global Acute Kidney Injury Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. Global Acute Kidney Injury Treatment Market Size Share by Application (2021-2026)
Table 38. North America Key Players Acute Kidney Injury Treatment Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Acute Kidney Injury Treatment Market Share (2019-2020)
Table 40. North America Acute Kidney Injury Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. North America Acute Kidney Injury Treatment Market Share by Type (2015-2020)
Table 42. North America Acute Kidney Injury Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. North America Acute Kidney Injury Treatment Market Share by Application (2015-2020)
Table 44. Europe Key Players Acute Kidney Injury Treatment Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Acute Kidney Injury Treatment Market Share (2019-2020)
Table 46. Europe Acute Kidney Injury Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Acute Kidney Injury Treatment Market Share by Type (2015-2020)
Table 48. Europe Acute Kidney Injury Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Acute Kidney Injury Treatment Market Share by Application (2015-2020)
Table 50. China Key Players Acute Kidney Injury Treatment Revenue (2019-2020) (Million US$)
Table 51. China Key Players Acute Kidney Injury Treatment Market Share (2019-2020)
Table 52. China Acute Kidney Injury Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. China Acute Kidney Injury Treatment Market Share by Type (2015-2020)
Table 54. China Acute Kidney Injury Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. China Acute Kidney Injury Treatment Market Share by Application (2015-2020)
Table 56. Japan Key Players Acute Kidney Injury Treatment Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Acute Kidney Injury Treatment Market Share (2019-2020)
Table 58. Japan Acute Kidney Injury Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Acute Kidney Injury Treatment Market Share by Type (2015-2020)
Table 60. Japan Acute Kidney Injury Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Acute Kidney Injury Treatment Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Acute Kidney Injury Treatment Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Acute Kidney Injury Treatment Market Share (2019-2020)
Table 64. Southeast Asia Acute Kidney Injury Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Acute Kidney Injury Treatment Market Share by Type (2015-2020)
Table 66. Southeast Asia Acute Kidney Injury Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Acute Kidney Injury Treatment Market Share by Application (2015-2020)
Table 68. India Key Players Acute Kidney Injury Treatment Revenue (2019-2020) (Million US$)
Table 69. India Key Players Acute Kidney Injury Treatment Market Share (2019-2020)
Table 70. India Acute Kidney Injury Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. India Acute Kidney Injury Treatment Market Share by Type (2015-2020)
Table 72. India Acute Kidney Injury Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. India Acute Kidney Injury Treatment Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Acute Kidney Injury Treatment Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Acute Kidney Injury Treatment Market Share (2019-2020)
Table 76. Central & South America Acute Kidney Injury Treatment Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Acute Kidney Injury Treatment Market Share by Type (2015-2020)
Table 78. Central & South America Acute Kidney Injury Treatment Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Acute Kidney Injury Treatment Market Share by Application (2015-2020)
Table 80. Quark Pharmaceuticals, Inc. Company Details
Table 81. Quark Pharmaceuticals, Inc. Business Overview
Table 82. Quark Pharmaceuticals, Inc. Product
Table 83. Quark Pharmaceuticals, Inc. Revenue in Acute Kidney Injury Treatment Business (2015-2020) (Million US$)
Table 84. Quark Pharmaceuticals, Inc. Recent Development
Table 85. Baxter International, Inc. Company Details
Table 86. Baxter International, Inc. Business Overview
Table 87. Baxter International, Inc. Product
Table 88. Baxter International, Inc. Revenue in Acute Kidney Injury Treatment Business (2015-2020) (Million US$)
Table 89. Baxter International, Inc. Recent Development
Table 90. Fresenius Medical Care AG & Co. KGaA Company Details
Table 91. Fresenius Medical Care AG & Co. KGaA Business Overview
Table 92. Fresenius Medical Care AG & Co. KGaA Product
Table 93. Fresenius Medical Care AG & Co. KGaA Revenue in Acute Kidney Injury Treatment Business (2015-2020) (Million US$)
Table 94. Fresenius Medical Care AG & Co. KGaA Recent Development
Table 95. LG Chem Company Details
Table 96. LG Chem Business Overview
Table 97. LG Chem Product
Table 98. LG Chem Revenue in Acute Kidney Injury Treatment Business (2015-2020) (Million US$)
Table 99. LG Chem Recent Development
Table 100. Asahi Kasei Medical Co., Ltd. Company Details
Table 101. Asahi Kasei Medical Co., Ltd. Business Overview
Table 102. Asahi Kasei Medical Co., Ltd. Product
Table 103. Asahi Kasei Medical Co., Ltd. Revenue in Acute Kidney Injury Treatment Business (2015-2020) (Million US$)
Table 104. Asahi Kasei Medical Co., Ltd. Recent Development
Table 105. B. Braun Melsungen AG Company Details
Table 106. B. Braun Melsungen AG Business Overview
Table 107. B. Braun Melsungen AG Product
Table 108. B. Braun Melsungen AG Revenue in Acute Kidney Injury Treatment Business (2015-2020) (Million US$)
Table 109. B. Braun Melsungen AG Recent Development
Table 110. Angion Biomedica Corp Company Details
Table 111. Angion Biomedica Corp Business Overview
Table 112. Angion Biomedica Corp Product
Table 113. Angion Biomedica Corp Revenue in Acute Kidney Injury Treatment Business (2015-2020) (Million US$)
Table 114. Angion Biomedica Corp Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Global Acute Kidney Injury Treatment Market Share by Type: 2020 VS 2026
Figure 2. Prerenal Acute Kidney Injury Features
Figure 3. Postrenal Acute Kidney Injury Features
Figure 4. Intrinsic Renal Acute Kidney Injury Features
Figure 5. Global Acute Kidney Injury Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Ambulatory Surgical Centers Case Studies
Figure 8. Others Case Studies
Figure 9. Acute Kidney Injury Treatment Report Years Considered
Figure 10. Global Acute Kidney Injury Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Acute Kidney Injury Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Acute Kidney Injury Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Acute Kidney Injury Treatment Market Share by Players in 2019
Figure 15. Global Top Acute Kidney Injury Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Kidney Injury Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Acute Kidney Injury Treatment Revenue in 2019
Figure 17. North America Acute Kidney Injury Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Acute Kidney Injury Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Acute Kidney Injury Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Acute Kidney Injury Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Acute Kidney Injury Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Acute Kidney Injury Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Acute Kidney Injury Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Quark Pharmaceuticals, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Quark Pharmaceuticals, Inc. Revenue Growth Rate in Acute Kidney Injury Treatment Business (2015-2020)
Figure 26. Baxter International, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Baxter International, Inc. Revenue Growth Rate in Acute Kidney Injury Treatment Business (2015-2020)
Figure 28. Fresenius Medical Care AG & Co. KGaA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Fresenius Medical Care AG & Co. KGaA Revenue Growth Rate in Acute Kidney Injury Treatment Business (2015-2020)
Figure 30. LG Chem Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. LG Chem Revenue Growth Rate in Acute Kidney Injury Treatment Business (2015-2020)
Figure 32. Asahi Kasei Medical Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Asahi Kasei Medical Co., Ltd. Revenue Growth Rate in Acute Kidney Injury Treatment Business (2015-2020)
Figure 34. B. Braun Melsungen AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. B. Braun Melsungen AG Revenue Growth Rate in Acute Kidney Injury Treatment Business (2015-2020)
Figure 36. Angion Biomedica Corp Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Angion Biomedica Corp Revenue Growth Rate in Acute Kidney Injury Treatment Business (2015-2020)
Figure 38. Bottom-up and Top-down Approaches for This Report
Figure 39. Data Triangulation
Figure 40. Key Executives Interviewed


More Publications